Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Dove Medical Press
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500143/ |